Ixazomib-dexamethasone versus physician's choice in patients with relapsed/refractory systemic AL amyloidosis: Primary data from the phase 3 TOURMALINE-AL1 trial Meeting Abstract
| Authors: | Wechalekar, A. D.; Dispenzieri, A.; Kastritis, E.; Schonland, S. O.; Kim, K.; Sanchorawala, V.; Landau, H. J.; Kwok, F.; Suzuki, K.; Comenzo, R. L.; Berg, D.; Liu, G.; Faller, D. V.; Merlini, G. |
| Abstract Title: | Ixazomib-dexamethasone versus physician's choice in patients with relapsed/refractory systemic AL amyloidosis: Primary data from the phase 3 TOURMALINE-AL1 trial |
| Meeting Title: | 60th Annual Scientific Meeting of the British Society for Haematology (BSH) |
| Journal Title: | British Journal of Haematology |
| Volume: | 189 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Apr 27-29 |
| Meeting Location: | Birmingham, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2020-04-01 |
| Start Page: | 24 |
| End Page: | 25 |
| Language: | English |
| ACCESSION: | WOS:000528597400024 |
| PROVIDER: | wos |
| PUBMED: | 32337705 |
| DOI: | 10.1111/bjh.16638 |
| Notes: | Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-OR-022 -- Source: Wos |
